It was specifically embodied as that IGF-1, activator of PI3K/AKT/mTOR signaling, could, to some extent, reverse the effect of si-SRPX2 on proliferation, migration, invasion and gemcitabine/5-Fu-tolerance of PC cells (Figure 4). The gene discussed is MTOR; the disease is pachyonychia congenita.